These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8397421)

  • 21. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
    Bidlack JM; O'Malley WE; Schulz R
    Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carboxyl terminus of delta opioid receptor is required for agonist-dependent receptor phosphorylation.
    Zhao J; Pei G; Huang YL; Zhong FM; Ma L
    Biochem Biophys Res Commun; 1997 Sep; 238(1):71-6. PubMed ID: 9299454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and characterization of a delta opioid receptor from zebrafish.
    Barrallo A; Malvar FG; Gonzalez R; Rodriguez RE; Traynor JR
    Biochem Soc Trans; 1998 Nov; 26(4):S360. PubMed ID: 10047874
    [No Abstract]   [Full Text] [Related]  

  • 24. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of the expression of delta opioid receptor mRNA by long-term exposure of NG-108-15 cell line to delta opioid agonists].
    Wang Y; Wang XM; Han JS
    Sheng Li Xue Bao; 1998 Apr; 50(2):217-21. PubMed ID: 11324539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A delta opioid receptor lacking the third cytoplasmic loop is generated by atypical mRNA processing in human malignomas.
    Mayer P; Tischmeyer H; Jayasinghe M; Bonnekoh B; Gollnick H; Teschemacher H; Höllt V
    FEBS Lett; 2000 Sep; 480(2-3):156-60. PubMed ID: 11034319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different subtypes of opioid receptors have different affinities for G-proteins.
    Polastron J; Jauzac P
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):389-401. PubMed ID: 7920183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of delta opioid receptor and N-methyl-D-aspartate receptor-like immunoreactivity in retinoic acid-differentiated neuroblastoma x glioma (NG108-15) cells.
    Beczkowska IW; Gracy KN; Pickel VM; Inturrisi CE
    J Neurosci Res; 1997 Jan; 47(1):83-9. PubMed ID: 8981241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.
    Selley DE; Bidlack JM
    J Pharmacol Exp Ther; 1992 Oct; 263(1):99-104. PubMed ID: 1328614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
    Belcheva MM; Barg J; Gloeckner C; Gao XM; Chuang DM; Coscia CJ
    Mol Pharmacol; 1992 Sep; 42(3):445-52. PubMed ID: 1328845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG; Traynor JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
    J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid regulation of AP-1 DNA-binding activity in NG108-15 cells under conditions of opioid-receptor adaptation.
    Tencheva ZS; Belcheva MM; Velichkova AA; Lissichkova EG; Coscia CJ
    Brain Res Mol Brain Res; 1997 Aug; 48(1):156-8. PubMed ID: 9379837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific reduction of delta-opioid receptor binding in transfected NG108-15 cells.
    Ann DK; Hasegawa J; Ko JL; Chen ST; Lee NM; Loh HH
    J Biol Chem; 1992 Apr; 267(11):7921-6. PubMed ID: 1313812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.
    Kieffer BL; Befort K; Gavériaux-Ruff C; Hirth CG
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1193. PubMed ID: 8302853
    [No Abstract]   [Full Text] [Related]  

  • 37. Tools for dissecting signaling pathways in vivo: receptors activated solely by synthetic ligands.
    Scearce-Levie K; Coward P; Redfern CH; Conklin BR
    Methods Enzymol; 2002; 343():232-48. PubMed ID: 11665570
    [No Abstract]   [Full Text] [Related]  

  • 38. Biosynthesis of substance P in cultured mouse neuroblastoma and rat glioma cells.
    Harkins J; Roper M; Ham RG; Stewart JM
    Brain Res; 1978 May; 147(2):405-9. PubMed ID: 647408
    [No Abstract]   [Full Text] [Related]  

  • 39. [K+ channels: their function and structure in NG-108-15 neuroblastoma cells].
    Higashida H; Yokoyama S; Kawamura T; Ito Y; Fukuda K; Ogura A
    Seikagaku; 1992 Apr; 64(4):219-36. PubMed ID: 1593187
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatment.
    Standifer KM
    Methods Enzymol; 2000; 314():90-103. PubMed ID: 10565007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.